NCT00411957View on ClinicalTrials.gov

Pharmacokinetic Study of 2 Doses of ATV/r OD + 2 NRTIs in Thai HIV-1 Infected Patients

PHASE1/PHASE2CompletedINTERVENTIONAL

Enrollment

22

Participants

Timeline

Start Date

January 31, 2007

Primary Completion Date

January 31, 2008

Study Completion Date

January 31, 2008

Conditions

HIV Infections

Interventions

DRUG

Atazanavir

ATV/r 300/100mg OD vs ATV/r 200/100 mg OD

Trial Locations (1)

10300

HIV-NAT, Thai Red Cross AIDS Research Center, Bangkok

Sponsors

Collaborators (1)

Bristol-Myers Squibb

All Listed Sponsors

collaborator

Bristol-Myers Squibb

INDUSTRY

lead

The HIV Netherlands Australia Thailand Research Collaboration

OTHER

NCT00411957 - Pharmacokinetic Study of 2 Doses of ATV/r OD + 2 NRTIs in Thai HIV-1 Infected Patients | Biotech Hunter | Biotech Hunter